Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04661072 · ClinicalTrials.gov registry record
Congenital Uterine Anomalies: Identifying Cancer Associations and Genetic and Environmental Factors to Improve Clinical Care
A clinical trial of Congenital Uterine Anomaly, sponsored by Yale University.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT04661072 is a study of Congenital Uterine Anomaly that is actively recruiting participants, run by Yale University. The registered enrollment target is 300 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04661072, a study of Congenital Uterine Anomaly, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to learn more about the health outcomes associated with congenital uterine anomalies (CUAs), and the possible environmental and genetic causes of the condition. The researchers plan to investigate whether any cancer associations (with breast, renal, ovarian, vaginal and uterine cancers) exist in females with CUAs. The investigator will also investigate any environmental and genetic factors that may be responsible for causing CUAs.
Conditions Studied
Study Locations (1)
Connecticut
- Yale University - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2021-07-14 |
| Est. Completion | 2027-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04661072
The ClinicalTrials.gov registry entry for NCT04661072 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Congenital Uterine Anomaly appearing as the primary indexed condition, and to 0 interventions.
NCT04661072 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT04661072 about?
NCT04661072 is a clinical study titled "Congenital Uterine Anomalies: Identifying Cancer Associations and Genetic and Environmental Factors to Improve Clinical Care". The purpose of this research study is to learn more about the health outcomes associated with congenital uterine anomalies (CUAs), and the possible environmental and genetic causes of the condition. The researchers plan to investigate whether any cancer associations (with breast, renal, ovarian, vag...
What is the current status of trial NCT04661072?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2021-07-14. Estimated completion is 2027-08.
What conditions does trial NCT04661072 study?
This clinical trial studies the following conditions: Congenital Uterine Anomaly.
Who is sponsoring clinical trial NCT04661072?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04661072 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.